3.1. Patient Characteristics
The intervention group consisted of 22 patients. The control group consisted of 10 patients. Patients in the control group were included from December 2020 to March 2021 and patients in the intervention group from March 2021 to August 2021. Standard regimes of chemotherapy remained the same in these periods. Baseline patient characteristics are provided in There was no significant difference between the two groups as concerns the starting dose or cumulative dose of oxaliplatin after three cycles of chemotherapy (The intervention group received a larger cumulative dose of capecitabine (The starting dose of chemotherapy in the control and intervention groups as well as the cumulative dose during the three cycles of chemotherapy can be seen in 